Biolinq develops a biowearable platform with tiny under-skin sensors that monitor metabolic health, including glucose, by sensing multiple analytes. The sensors continuously collect data below the skin and transmit to an app or clinician for insights and personalized medicine. It differentiates by being a small, under-skin, multi-analyte system backed by university bioengineering research, not external wearables or single markers. Its goal is to gain regulatory approval and bring scalable, continuous metabolic health monitoring to patients.
Company Size
51-200
Company Stage
Series C
Total Funding
$316.4M
Headquarters
San Diego, California
Founded
2012
See people who can refer or advise you
Help us improve and share your feedback! Did you find this helpful?